[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL1784404T3 - Pochodne pirolo[2,3-c]pirydyny i sposoby ich wytwarzania - Google Patents

Pochodne pirolo[2,3-c]pirydyny i sposoby ich wytwarzania

Info

Publication number
PL1784404T3
PL1784404T3 PL05808813T PL05808813T PL1784404T3 PL 1784404 T3 PL1784404 T3 PL 1784404T3 PL 05808813 T PL05808813 T PL 05808813T PL 05808813 T PL05808813 T PL 05808813T PL 1784404 T3 PL1784404 T3 PL 1784404T3
Authority
PL
Poland
Prior art keywords
pyrrolo
pyridine derivatives
processes
preparation
pharmaceutically acceptable
Prior art date
Application number
PL05808813T
Other languages
English (en)
Inventor
Jae-Gyu Kim
Byung-Nak Ahn
Hyouk-Woo 405-202 Jugong Greenvil Apt Lee
Suk-Won Yoon
Young-Ae 502-1006 Munrae Hyundai 5Cha Apt Yoon
Dong-Hoon Kim
Chan-Sun Park
Seok-Hee Han
Myung-Hun 105-1601 Jugong Tteuranchae Apt Cha
Heui-Il Kang
Ryong Choi
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Publication of PL1784404T3 publication Critical patent/PL1784404T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL05808813T 2004-09-03 2005-09-03 Pochodne pirolo[2,3-c]pirydyny i sposoby ich wytwarzania PL1784404T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20040070533 2004-09-03
PCT/KR2005/002927 WO2006025716A1 (en) 2004-09-03 2005-09-03 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
EP05808813A EP1784404B1 (en) 2004-09-03 2005-09-03 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof

Publications (1)

Publication Number Publication Date
PL1784404T3 true PL1784404T3 (pl) 2012-04-30

Family

ID=36000318

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05808813T PL1784404T3 (pl) 2004-09-03 2005-09-03 Pochodne pirolo[2,3-c]pirydyny i sposoby ich wytwarzania

Country Status (17)

Country Link
US (2) US7662832B2 (pl)
EP (1) EP1784404B1 (pl)
JP (1) JP4898683B2 (pl)
KR (3) KR100958830B1 (pl)
CN (1) CN101018789B (pl)
AT (1) ATE533765T1 (pl)
AU (1) AU2005280740B2 (pl)
BR (1) BRPI0514925A (pl)
CA (1) CA2579087C (pl)
DK (1) DK1784404T3 (pl)
ES (1) ES2373672T3 (pl)
HK (1) HK1105979A1 (pl)
MX (1) MX2007002324A (pl)
PL (1) PL1784404T3 (pl)
PT (1) PT1784404E (pl)
RU (1) RU2385320C2 (pl)
WO (2) WO2006025716A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1787991B2 (en) † 2004-07-28 2020-06-24 Takeda Pharmaceutical Company Limited PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE
MX2007002324A (es) * 2004-09-03 2007-05-11 Yuhan Corp Derivados de pirrolo[2-3-c]piridina y procesos para la preparacion de los mismos.
US7906528B2 (en) * 2004-10-05 2011-03-15 Novartis International Pharmaceutical Ltd. Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds
GB0525143D0 (en) * 2005-12-09 2006-01-18 Novartis Ag Organic compounds
EP2452680B1 (en) 2009-07-09 2019-12-18 RaQualia Pharma Inc. Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
CN102875549B (zh) * 2012-09-14 2015-11-04 浙江大学 7-芳（甲）胺基-5-胺基-6-氮杂吲哚衍生物及制备与用途
US9045477B2 (en) * 2013-03-15 2015-06-02 Epizyme, Inc. Substituted 6,5-fused bicyclic heteroaryl compounds
KR101657597B1 (ko) * 2013-05-08 2016-09-19 주식회사유한양행 피롤로[2,3-c]피리딘 유도체 또는 이의 약학적으로 허용가능한 염의 제조방법
KR101657599B1 (ko) * 2013-05-20 2016-09-19 주식회사유한양행 피롤로[2,3-c]피리딘 유도체 또는 이의 약학적으로 허용가능한 염의 제조방법
BG111544A (bg) 2013-07-29 2015-01-30 Николай Цветков Субституирани бензамидни производни като in vitro mao-b инхибитори
KR102084185B1 (ko) 2013-08-29 2020-03-04 주식회사 대웅제약 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법
KR102129842B1 (ko) * 2013-10-02 2020-07-06 주식회사 대웅제약 술포닐인돌 유도체 및 이의 제조방법
WO2015125858A1 (ja) * 2014-02-24 2015-08-27 日本曹達株式会社 ヘテロアリール化合物およびその用途
CN105440016B (zh) * 2014-08-11 2018-08-31 江苏柯菲平医药股份有限公司 吲哚、氮杂吲哚类衍生物、其制备方法及其在医药上的应用
MA41850A (fr) 2015-03-31 2018-02-06 Takeda Pharmaceuticals Co Nouvelles utilisations pharmaceutiques
KR101613245B1 (ko) 2015-04-27 2016-04-18 주식회사 대웅제약 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
MY190795A (en) * 2016-04-15 2022-05-12 Abbvie Inc Bromodomain inhibitors
KR101777971B1 (ko) 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
CN108164455A (zh) * 2017-03-23 2018-06-15 广东众生药业股份有限公司 马来酸非尼拉敏的合成方法
KR102233456B1 (ko) * 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR20190057569A (ko) 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
CN110117284B (zh) * 2018-02-06 2021-11-19 江苏奥赛康药业有限公司 含氮杂环类化合物及其制备方法和用途
EP3897670A4 (en) 2018-12-19 2022-09-07 Disarm Therapeutics, Inc. MRSA1 INHIBITORS IN COMBINATION WITH NEUROPROTECTIVE AGENTS
CN112300170B (zh) * 2019-07-26 2022-01-21 上海美迪西生物医药股份有限公司 吡咯并吡唑类衍生物、其制备方法及其在医药上的应用
CN112300169B (zh) * 2019-07-26 2022-03-04 上海美迪西生物医药股份有限公司 吡咯并吡唑类衍生物、其制备方法及其在医药上的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068378B1 (en) 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4428962A (en) * 1981-10-30 1984-01-31 Schering Corporation Indoles in treatment of peptic ulcers
JPH0611670A (ja) * 1992-06-25 1994-01-21 Hitachi Ltd 光強度変調素子および光強度変調器
JP3465827B2 (ja) * 1993-02-24 2003-11-10 株式会社日清製粉グループ本社 アザインドール誘導体およびこれを有効成分とする抗潰瘍薬
JP3143571B2 (ja) * 1994-01-19 2001-03-07 三共株式会社 ピロロピリダジン誘導体
ES2201112T3 (es) 1994-08-13 2004-03-16 Yuhan Corporation Nuevos derivados de pirimidina y procedimientos para su preparacion.
GB2298199A (en) * 1995-02-21 1996-08-28 Merck Sharp & Dohme Synthesis of azaindoles
FR2732969B1 (fr) * 1995-04-14 1997-05-16 Adir Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SE9700661D0 (sv) 1997-02-25 1997-02-25 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
RS50145B (sr) 1998-09-23 2009-03-25 Altana Pharma Ag., Tetrahidropiridoetri
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
JP2003119140A (ja) * 2001-08-08 2003-04-23 Sankyo Co Ltd ピロロピリダジン化合物を含有する医薬
US7361671B2 (en) 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids
TW200301251A (en) * 2001-12-20 2003-07-01 Wyeth Corp Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
PT1753764E (pt) * 2004-06-09 2009-01-28 Glaxo Group Ltd Derivados de pirrolopiridina
EP1787991B2 (en) * 2004-07-28 2020-06-24 Takeda Pharmaceutical Company Limited PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE
MX2007002324A (es) * 2004-09-03 2007-05-11 Yuhan Corp Derivados de pirrolo[2-3-c]piridina y procesos para la preparacion de los mismos.

Also Published As

Publication number Publication date
WO2006025716A1 (en) 2006-03-09
EP1784404A4 (en) 2009-09-09
KR100958829B1 (ko) 2010-05-25
EP1784404A1 (en) 2007-05-16
RU2385320C2 (ru) 2010-03-27
KR20100039325A (ko) 2010-04-15
ES2373672T3 (es) 2012-02-07
AU2005280740A1 (en) 2006-03-09
CA2579087C (en) 2012-05-01
CN101018789A (zh) 2007-08-15
US20070219230A1 (en) 2007-09-20
PT1784404E (pt) 2011-12-09
WO2006025717A1 (en) 2006-03-09
DK1784404T3 (da) 2012-02-13
KR20060051006A (ko) 2006-05-19
JP4898683B2 (ja) 2012-03-21
BRPI0514925A (pt) 2008-07-01
MX2007002324A (es) 2007-05-11
KR100958830B1 (ko) 2010-05-24
KR20060051005A (ko) 2006-05-19
AU2005280740B2 (en) 2011-04-28
HK1105979A1 (en) 2008-02-29
CA2579087A1 (en) 2006-03-09
EP1784404B1 (en) 2011-11-16
US20100069430A1 (en) 2010-03-18
KR101049068B1 (ko) 2011-07-15
JP2008511621A (ja) 2008-04-17
RU2007112110A (ru) 2008-10-10
US7662832B2 (en) 2010-02-16
ATE533765T1 (de) 2011-12-15
CN101018789B (zh) 2010-09-08
US8188114B2 (en) 2012-05-29

Similar Documents

Publication Publication Date Title
HK1105979A1 (en) Pyrrolo [3,2-c] pyridine derivatives and processes for the preparation
HK1105977A1 (en) Pyrrolo [3,2-c] pyridine derivatives and processes for the preparation
UA83091C2 (en) Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
WO2006011050A3 (en) Pyridine derivatives
WO2006126082A3 (en) Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
WO2004063151A3 (en) Novel tyrosine kinase inhibitors
WO2005049581A8 (en) Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
WO2004031401A3 (en) Novel tyrosine kinases inhibitors
MY132106A (en) New pyridazin-3(2h)-one derivatives
WO2002036562A3 (en) 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
WO2006116733A3 (en) Protein kinase inhibitors
WO2003053359A3 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
WO2006023515A3 (en) Novel thiazole inhibitors of fructose 1,6-bisphosphatase
WO2005037197A3 (en) Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
WO2005004808A3 (en) TETRACYCLIC COMPOUNDS AS c-MET INHIBITORS
WO2004105737A3 (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
WO2004110990A3 (en) Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
WO2006124865A3 (en) Biaryls derivatives useful as modulators of ion channels
HK1105978A1 (en) Pyrrolo [3,2-c]pyridine derivatives and processes for the preparation thereof
IL161842A (en) 2-amino-4-heteroarylethyl-thiazoline derivatives and pharmaceutical compositions comprising them
WO2004056832A3 (en) Epothilone derivatives
WO2006110173A3 (en) Novel compounds